Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.

Sun J, Tao S, Gao Y, Peng T, Tan A, Zhang H, Yang X, Qin X, Hu Y, Feng J, Kim ST, Lin X, Wu Y, Zhang J, Li Z, Li L, Mo L, Liang Z, Shi D, Huang Z, Huang X, Liu M, Liu Q, Zhang S, Lilly Zheng S, Xu J, Mo Z.

Hum Genet. 2013 Apr;132(4):423-9. doi: 10.1007/s00439-012-1254-3. Epub 2012 Dec 27.

PMID:
23269536
2.
3.

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

Cramer SD, Chang BL, Rao A, Hawkins GA, Zheng SL, Wade WN, Cooke RT, Thomas LN, Bleecker ER, Catalona WJ, Sterling DA, Meyers DA, Ohar J, Xu J.

J Natl Cancer Inst. 2003 Jul 16;95(14):1044-53.

PMID:
12865450
4.

Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men.

Nobata S, Hishida A, Naito M, Asai Y, Mori A, Kuwabara M, Katase S, Okada R, Morita E, Kawai S, Hamajima N, Wakai K.

Urol Int. 2012;89(1):39-44. doi: 10.1159/000332197. Epub 2012 Mar 14.

PMID:
22433834
5.

A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.

Terao C, Terada N, Matsuo K, Kawaguchi T, Yoshimura K, Hayashi N, Shimizu M, Soga N, Takahashi M; Nagahama Cohort Study Group, Kotoura Y, Yamada R, Ogawa O, Matsuda F.

J Med Genet. 2014 Aug;51(8):530-6. doi: 10.1136/jmedgenet-2014-102423. Epub 2014 Jun 11.

PMID:
24919509
6.

Genetic correction of PSA values using sequence variants associated with PSA levels.

Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K.

Sci Transl Med. 2010 Dec 15;2(62):62ra92. doi: 10.1126/scitranslmed.3001513.

7.

Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.

He D, Wang M, Chen X, Gao Z, He H, Zhau HE, Wang W, Chung LW, Nan X.

Urology. 2004 Apr;63(4):722-6.

PMID:
15072888
8.

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.

Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.

Carcinogenesis. 2011 Jun;32(6):853-9. doi: 10.1093/carcin/bgr050. Epub 2011 Mar 18.

9.

Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.

Jin G, Zheng SL, Lilja H, Kim ST, Tao S, Gao Z, Young T, Wiklund F, Feng J, Isaacs WB, Rittmaster RS, Gronberg H, Condreay LD, Sun J, Xu J.

Neoplasia. 2013 Jan;15(1):95-101.

10.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
11.

Genome-wide scan on total serum IgE levels identifies no common variants in a healthy Chinese male population.

Liao M, Shi D, Wang Y, Zhang K, Chen X, Gao Y, Tan A, Xuan Q, Yang X, Hu Y, Qin X, Zhang H, Mo Z.

Immunogenetics. 2013 Aug;65(8):561-8. doi: 10.1007/s00251-013-0706-9. Epub 2013 May 10.

PMID:
23661040
12.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

PMID:
19726753
13.

Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.

Beebe-Dimmer JL, Lange LA, Cain JE, Lewis RC, Ray AM, Sarma AV, Lange EM, Cooney KA.

Prostate Cancer Prostatic Dis. 2006;9(1):50-5.

PMID:
16247489
14.

Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.

Qi TY, Chen YQ, Jiang J, Zhu YK, Yao XH, Wang XJ.

Int Urol Nephrol. 2012 Jun;44(3):807-15. doi: 10.1007/s11255-011-0119-3. Epub 2012 Feb 5.

PMID:
22311386
15.

Distribution of serum prostate-specific antigen in Chinese healthy men: a population-based study.

Yuan XD, Dong ZG, Zhang H, Lin HY, Song XH, Niu ZH, Fu Q, Liu S, Sun ZJ, Lü JJ.

Chin Med J (Engl). 2011 Apr;124(8):1189-92.

PMID:
21542994
16.

8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.

Chan JY, Li H, Singh O, Mahajan A, Ramasamy S, Subramaniyan K, Kanesvaran R, Sim HG, Chong TW, Teo YY, Chia SE, Tan MH, Chowbay B.

Urol Oncol. 2013 Nov;31(8):1553-60. doi: 10.1016/j.urolonc.2012.02.009. Epub 2012 May 5.

PMID:
22561070
17.

Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin.

Pal P, Xi H, Sun G, Kaushal R, Meeks JJ, Thaxton CS, Guha S, Jin CH, Suarez BK, Catalona WJ, Deka R.

Hum Genet. 2007 Nov;122(3-4):251-9. Epub 2007 Jun 26.

PMID:
17593395
18.

A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.

Parikh H, Deng Z, Yeager M, Boland J, Matthews C, Jia J, Collins I, White A, Burdett L, Hutchinson A, Qi L, Bacior JA, Lonsberry V, Rodesch MJ, Jeddeloh JA, Albert TJ, Halvensleben HA, Harkins TT, Ahn J, Berndt SI, Chatterjee N, Hoover R, Thomas G, Hunter DJ, Hayes RB, Chanock SJ, Amundadottir L.

Hum Genet. 2010 Jan;127(1):91-9. doi: 10.1007/s00439-009-0751-5. Epub 2009 Oct 13.

19.

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.

Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG.

Br J Cancer. 2002 Sep 23;87(7):726-8.

20.

Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.

Chang BL, Hughes L, Chen DY, Gross L, Ruth K, Giri VN.

BJU Int. 2014 May;113(5b):E150-6. doi: 10.1111/bju.12264. Epub 2013 Aug 13.

Supplemental Content

Support Center